Sage Therapeutics Inc. sell StockNews.com
Start price
07.06.25
/
50%
€5.93
Target price
07.06.26
-
Performance (%)
27.78%
Price
31.07.25
€7.60
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 27.78%. This prediction currently runs until 07.06.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sage Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by StockNews_com for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by StockNews_com for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.32
20.04.24
20.04.24
-
20.04.25
20.04.25
-46.75%
21.04.25
21.04.25
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€18.10
20.08.23
20.08.23
-
20.08.24
20.08.24
-58.06%
21.08.24
21.08.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.40
12.08.23
12.08.23
-
12.08.24
12.08.24
-63.58%
13.08.24
13.08.24